Monocyte superoxide production is inversely related to normal content of α-tocopherol in low-density lipoprotein

Atherosclerosis

Volumn 138, Issue 2, 1998, Pages 263-269

  Cachia, Odile ^a   Léger, Claude L ^a   Descomps, Bernard ^a  

^a EA 2033 Inst de Biol Fac de M   (France)

Author keywords

Atherogenesis; Human adherent monocyte; Low density lipoprotein; Superoxide; Vitamin E ( tocopherol)

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE;

ACETYLATION; ARTICLE; ATHEROGENESIS; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL;

ARTERIOSCLEROSIS; CELLS, CULTURED; FREE RADICAL SCAVENGERS; HUMANS; LIPOPROTEINS, LDL; MONOCYTES; OXIDATIVE STRESS; SUPEROXIDES; VITAMIN E;

EID: 0032103176     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00028-8     Document Type: Article

References (42)

1. Machlin L.J., Gabriel E. Interactions of vitamin E with vitamin C, vitamin B12 and zinc. Ann NY Acad Sci. 355:1980;98-108.
2. Liebler DC, Burr JA Antioxidant stoichiometry and the antioxidative fate of vitamin E in peroxyl scavenging reactions. Lipids. 30:1995;789-793.
3. Burton GW, Joyce A, Ingold KU Is vitamin E the only lipid soluble chain breaking antioxidant in human blood plasma and erythrocytes? Arch Biochem Biophys. 221:1983;281-290.
4. Sokol RJ Vitamin E deficiency and neurologic disease. Ann Rev Nutr. 8:1988;351-373.
5. Esterbauer H, Striegl G, Phul H, Rhoteneder M Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comm. 6:1989;67-75.
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL Beyond cholesterol: modifications of low-density lipoproteins that increase its atherogenicity. New Engl J Med. 320:1989;915-924.
7. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785-1792.
8. Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res. 32:1991;1325-1332.
9. Janero DR Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis. Free Rad Biol Med. 11:1991;129-144.
10. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet. 347:1996;781-786.
11. Steiner M Vitamin E: more than an antioxidant. Clin Cardiol. 16:1993;I16-I18.
12. Faruqi R, De-la-Motte C, DiCorteto PE α-Tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest. 94:1994;592-600.
13. Chatelain E, Boscoboinik DO, Bartoli GM, Kagan VE, Gey FK, Packer L, Azzi A Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim Biophys Acta. 1176:1993;83-89.
14. Tran K, Chan AC R,R,R-α-tocopherol potentiates prostacyclin release in human endothelial cells. Evidence for structural specificity of the tocopherol molecule. Biochim Biophys Acta. 1043:1990;189-197.
15. Sakamoto W, Fujie K, Nishihira J, Handa H Effect of vitamin E on arachidonic acid release in rat peritoneal macrophages. Biochim Biophys Acta. 1170:1993;296-300.
16. Kanno T, Utsumi T, Kobuchi H, Takehara Y, Akiyama J, Yoshioka T, Horton AA, Utsumi K. Inhibition of stimulus-specific neutrophil superoxide generation by α-tocopherol. Free Rad Res. 22:1995;431-440.
17. Sakamoto W., Fujie K., Handa H., Ogihara T., Mino M In vivo inhibition of superoxide production and protein kinase C activity in macrophages from vitamin E-treated rats. Int J Vit Nutr Res. 60:1990;338-342.
18. Okano T., Tamai H., Mino M Superoxide generation in leukocytes and vitamin E. Int J Vit Nutr Res. 61:1991;20-26.
19. Yano T., Ichikawa T A mechanism of vitamin E-enhanced active oxygen formation in concanavalin A-stimulated alveolar macrophage. Biochem Mol Biol Int. 31:1993;291-296.
20. Devaraj S., Li D., Jialal I The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1b secretion, and monocyte adhesion to endothelium. J Clin Invest. 98:1996;756-763.
21. ·- production in human adherent monocytes. J Lipid Med Cell Sign. 11:1995;159-173.
22. Schumaker VN, Puppione DL Sequential flotation ultracentrifugation. Methods Enzymol. 128:1986;155-170.
23. Rumsey SC, Stucchi AF, Nicolosi RJ, Ginsberg HN, Ramakrishnan R, Deckelbaum RJ Human plasma LDL cryopreserved with sucrose maintains in vivo kinetics indistiguishable from freshly isolated human LDL in cynomolgus monkeys. J Lipid Res. 35:1994;1592-1598.
24. Basu SK, Goldstein JL, Anderson GW, Brown MS Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sc. 73:1976;3178-3182.
25. Cachia O, Léger CL, Boulot P, Vernet MH, Michel F, Crastes-de-Paulet A, Descomps B Red blood cell vitamin E concentrations in fetuses are related to but lower than those in mothers during gestation. A possible association with maternal Lp(a) plasma levels. Am J Obstet Gynecol. 173:1995;42-51.
26. Lowry OH, Roseborough NJ, Farr AL, Randall RJ Protein measurement with the folin phenol red reagent. J Biol Chem. 263:1951;10052-10055.
27. Corbisier P, Houbion A, Remacle J A new technique for highly sensitive detection of superoxide dismutase activity by chemiluminescence. Anal Biochem. 164:1987;240-247.
28. Johnston R.B., Godzick C.A., Cohn Z.A. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med. 148:1978;115-127.
29. Kadri-Hassani N., Léger C.L., Descomps B The fatty acid bimodal action on superoxide anion production by human adherent monocytes under phorbol 12-myristate 13-acetate or diacylglycerol activation can be explained by the modulation of protein kinase C and p47phox translocation. J Biol Chem. 270:1995;15111-15116.
30. Parthasarathy S., Rankin S.M. Role of oxidized low density lipoprotein in atherogenesis. Prog Lipid Res. 31:1992;127-143.
31. Juompan L., Puel J., Fournie G.J., Benoist H. Study of LDL and acetylated LDL endocytosis by mononuclear cells in HIV infection. Biochim Biophys Acta. 1272:1995;21-28.
32. Esterbauer H, Gebicki J, Puhl H, Jurgens G The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med. 13:1992;341-390.
33. Fogelman A.M., Haberland M.E., Seager J., Hokom M., Edwards P.A. Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages. J Lipid Res. 22:1981;1131-1141.
34. Azzi A, Boscoboinik D, Marilley D, Özer NK, Stäuble B Vitamin E: a sensor and an information transducer of the cell oxidation state. Am J Clin Nut. 62S:1995;1337S-1346.
35. Gey KF Ten year retrospective on the antioxidant hypothesis of arteriosclerosis: threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk. J Nutr Biochem. 6:1995;206-236.
36. Li Q, Cathcart MK Protein kinase C activity is required for lipid oxidation of low density lipoprotein by activated human monocytes. J Biol Chem. 269:1994;17508-17515.
37. Krieger M, Herz J Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor related-protein (LRP). Ann Rev Biochem. 63:1994;601-637.
38. Ohara Y., Petreson T.E., Zheng B., Kuo J.F., Harrison D.G. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb. 14:1994;1007-1013.
39. Tew D.G., Rice S.Q.J., Lawrence G.M.P., Li H., Boyd H.F., Moores K., Gloger I.S., Macphee C.H. Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins. Arterioscler Thromb Vasc Biol. 16:1996;591-599.
40. Quinn M.T., Parthasarathy S., Steinberg D. Lysophosphatidyl-choline: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sc. 85:1988;2805-2809.
41. Yokote K., Morisaki N., Zenibayashi M., Ueda S., Kansaki K., Saito Y., Yoshida S. The phospholipase-A2 reaction leads to increased monocytes adhesion of endothelial cells via the expression of adhesion molecules. Eur J Biochem. 217:1993;723-729.
42. x and complements α-tocopherol: physiological implications. Proc Natl Acad Sci. 94:1997;3217-3222.